Clinical Trial Finder Search Results

About the Fight CRC Clinical Trial Finder

This Trial Finder is a one-stop place to find and learn more about high-impact clinical trials for colorectal cancer patients with advanced colon or rectal cancer. Originally created by the late Dr. Tom Marsilje as a curated spreadsheet of trials, the FightCRC’s Trial Finder is a resource to find research studies that are open in your geography, and for which you may be eligible. The current data is now for metastatic, stage IV patients with both MSS and MSI-H status. The list of trials here is sourced from the ClinicalTrials.gov website and curated with Comments and Helpful Links. The searches can be focused on immunotherapy-centered trials and narrowed to studies enrolling patients who already have received immunotherapies.

Medical Disclaimer

The information contained in this website is not intended to recommend the self management of health problems, medical conditions or wellness. It is not intended to endorse or recommend any particular type of medical treatment, physician or treatment facility. Should any reader have any health care related questions, promptly call or consult your physician or healthcare provider. The information contained in this website should NOT be used by any reader to disregard medical and/or health related advice or provide a basis to delay consultation with a physician or a qualified healthcare provider. Fight Colorectal Cancer disclaims any liability based on information provided in this website.

Ubicación

MS status

Recruitment Status

Fase

Drogas

Inmunoterapia previa permitida

NCT ID

Title key word search

Fecha en que se añadió el juicio

From To

View:

Compact Expanded

PDF Excel CSV

NCT ID	Title	Fase	Date Added	Ubicación	Prior IO Allowed	CRC-directed	Status	Drogas	Etiquetas
NCT ID NCT02886585	TitlePembrolizumab In Central Nervous System Metastases	Fase Fase 2	Date Added 2016-09-01	Ubicación Massachusetts, United States	Prior IO Allowed No	CRC-directed No	Status Activo, no recluta	Drogas Pembrolizumab	Etiquetas MSS/ MMRp
NCT ID NCT03030378	TitlePembrolizumab e interleucina-12 recombinante en el tratamiento de pacientes con tumores sólidos	Fase Fase 1	Date Added 2017-01-25	Ubicación California, United States Colorado, United States Connecticut, United States Florida, United States Georgia, United States Iowa, United States Maryland, United States Massachusetts, United States Missouri, United States New Jersey, United States North Carolina, United States Ohio, United States Pennsylvania, United States Texas, United States Virginia, United States	Prior IO Allowed No	CRC-directed No	Status Activo, no recluta	Drogas Edodekin alfa, Pembrolizumab	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT05201612	TitlePembrolizumab y Olaparib en Cáncer Colorrectal Avanzado (CCR) Deficiente en Recombinación Homóloga (HRD).	Fase Fase 2	Date Added 2022-01-21	Ubicación España	Prior IO Allowed No	CRC-directed Sí	Status Unknown status	Drogas Olaparib, Pembrolizumab	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT05333809	TitlePembrolizumab and Disitamab Vedotin in HER2-expressing Metastatic Colorectal Cancer	Fase Fase 2	Date Added 2022-04-19	Ubicación	Prior IO Allowed No	CRC-directed Sí	Status Aún no se ha contratado	Drogas Disitamab vedotin, Pembrolizumab, Keytruda	Etiquetas MSS/ MMRp
NCT ID NCT05491083	TitlePembrolizumab and ADG106 in Advanced Solid Cancers and Triple Negative Breast Cancer	Fase Fase 1	Date Added 2022-08-08	Ubicación	Prior IO Allowed No	CRC-directed No	Status Aún no se ha contratado	Drogas Pembrolizumab & ADG106 (Phase Ib), Pembrolizumab & ADG106 (Phase II)	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT03844750	TitlePembrolizumab After Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver and Who Are Undergoing Liver Surgery	Fase Fase 2	Date Added 2019-02-18	Ubicación California, United States	Prior IO Allowed No	CRC-directed Sí	Status Activo, no recluta	Drogas Pembrolizumab, Vactosertib, Keytruda	Etiquetas MSS/ MMRp
NCT ID NCT03239145	TitlePembrolizumab (Anti-PD-1) and AMG386 (Angiopoietin-2 (Ang-2) in Patients With Advanced Solid Tumor	Fase Fase 1	Date Added 2017-08-03	Ubicación Massachusetts, United States	Prior IO Allowed No	CRC-directed Sí	Status Activo, no recluta	Drogas Pembrolizumab, Trebananib	Etiquetas MSS/ MMRp
NCT ID NCT03638297	TitlePD-1 Antibody Combined With COX Inhibitor in MSI-H/dMMR or High TMB Colorectal Cancer	Fase Fase 2	Date Added 2018-08-20	Ubicación China	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas PD-1 antibody + cox inhibitor	Etiquetas MSI-H/ MMRd
NCT ID NCT02215889	TitleEstudio de trasplante parcial del segmento hepático 2/3	Fase Fase 1	Date Added 2014-08-13	Ubicación Noruega	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT06764680	TitleOral Chemotherapy, Targeted Therapy and Immunotherapy With/without Radiotherapy As 3rd- or Later-line Therapy for Advanced MSS/pMMR Colorectal Cancer	Fase Fase 2	Date Added 2025-01-08	Ubicación China	Prior IO Allowed No	CRC-directed Sí	Status Aún no se ha contratado	Drogas	Etiquetas MSS/ MMRp

Showing 111 to 120 of 299 entries